Weller Harry R

10% owner at VONAGE HOLDINGS CORP · on record since May 23, 2006
Director at VONAGE HOLDINGS CORP · on record since Jun 12, 2006
Director at SOURCEFIRE INC · on record since Mar 13, 2007
10% owner at Clovis Oncology, Inc. · on record since Nov 22, 2011
10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 31, 2016
10% owner at Millennial Media Inc. · on record since Mar 28, 2012
10% owner at INTERLEUKIN GENETICS INC · on record since May 23, 2013
10% owner at TESARO, Inc. · on record since Jun 27, 2012
10% owner at Workday, Inc. · on record since Oct 18, 2012
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
Director at Omthera Pharmaceuticals, Inc. · on record since Jul 18, 2013
10% owner at Care.com Inc · on record since Jan 29, 2014
10% owner at HIVE Digital Technologies Ltd. · on record since Mar 27, 2014
10% owner at GLYCOMIMETICS INC · on record since Jan 15, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at Roka BioScience, Inc. · on record since Jul 22, 2014
10% owner at Journey Medical Corp · on record since Oct 8, 2014
10% owner at · on record since Jan 29, 2015
10% owner at · on record since Jan 29, 2015
10% owner at · on record since Mar 24, 2015
10% owner at · on record since Jun 17, 2015
10% owner at · on record since Jun 9, 2015
10% owner at · on record since Sep 30, 2015
10% owner at · on record since Jan 4, 2016
10% owner at · on record since May 17, 2016
10% owner at · on record since Jun 7, 2016
Director at · on record since Apr 3, 2014
10% owner at · on record since Oct 20, 2015
10% owner at · on record since Aug 14, 2013

Insider trading activity of Weller Harry R

Transactions on record: 169; since Jun 12, 2006

Open-market buys: 24; $162.5M

Open-market sells: 12; $67.8M

Companies traded: 22; last filing Oct 31, 2016

Figures computed from official regulatory filings — .

Companies where Weller Harry R has traded

10 tx · $4.4M · Oct 31, 2016
12 tx · $4.6M · Sep 30, 2016
4 tx · $4M · Aug 2, 2016
4 tx · $23.3M · Jul 20, 2016
20 tx · $65M · Mar 18, 2016
18 tx · $24M · Jan 12, 2016
2 tx · Oct 20, 2015
7 tx · $6M · Oct 6, 2015
1 tx · May 29, 2015
3 tx · $5M · Feb 5, 2015
5 tx · Jan 29, 2015
19 tx · $46.2M · Nov 28, 2014
5 tx · $1.1M · Oct 8, 2014
3 tx · $3M · Aug 6, 2014

Track record of Weller Harry R

Statistical track record

Free

Open-market buys: 29

Last buy: Oct 31, 2016

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Weller Harry R

Co-insiders of Weller Harry R

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	1,778,227	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	623,210	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Sell	-435	13.00 USD	$5.7K	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-80,658	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-4,689,657	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Buy	338,462	13.00 USD	$4.4M	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	80,658	0.07 USD	$5.6K	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	669,951	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-12,447,605	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-4,362,472	0.00 USD	—	SEC
Roka BioScience, Inc.	Sep 30, 2016	BuyD (derivative)	4,000	—	—	SEC
Roka BioScience, Inc.	Sep 23, 2016	BuyD (derivative)	4,000	—	—	SEC
Roka BioScience, Inc.	Sep 23, 2016	BuyD (derivative)	5,714,286	—	—	SEC
INTERLEUKIN GENETICS INC	Aug 2, 2016	Buy	20,120,724	0.10 USD	$2M	SEC
INTERLEUKIN GENETICS INC	Aug 2, 2016	BuyD (derivative)	20,120,724	0.00 USD	—	SEC
ARDELYX, INC.	Jul 20, 2016	Buy	763,651	8.73 USD	$6.7M	SEC
ARDELYX, INC.	Jul 20, 2016	Buy	763,650	8.73 USD	$6.7M	SEC
TESARO, Inc.	Mar 18, 2016	Buy	710,429	35.19 USD	$25M	SEC
TESARO, Inc.	Mar 18, 2016	Buy	710,429	35.19 USD	$25M	SEC
ARDELYX, INC.	Jan 14, 2016	Buy	500,000	10.00 USD	$5M	SEC
ARDELYX, INC.	Jan 14, 2016	Buy	500,000	10.00 USD	$5M	SEC
Epizyme, Inc.	Jan 12, 2016	Buy	1,111,111	9.00 USD	$10M	SEC
Avalo Therapeutics, Inc.	Oct 20, 2015	Other	594,245	—	—	SEC
Avalo Therapeutics, Inc.	Oct 20, 2015	OtherD (derivative)	-16,638,880	0.00 USD	—	SEC
Mirna Therapeutics, Inc.	Oct 6, 2015	OtherD (derivative)	-1,241,650	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	1,778,227	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	623,210	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Sell	-435	13.00 USD	$5.7K	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-80,658	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-4,689,657	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Buy	338,462	13.00 USD	$4.4M	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	80,658	0.07 USD	$5.6K	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	Other	669,951	—	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-12,447,605	0.00 USD	—	SEC
Ra Pharmaceuticals, Inc.	Oct 31, 2016	OtherD (derivative)	-4,362,472	0.00 USD	—	SEC
Roka BioScience, Inc.	Sep 30, 2016	BuyD (derivative)	4,000	—	—	SEC
Roka BioScience, Inc.	Sep 23, 2016	BuyD (derivative)	4,000	—	—	SEC
Roka BioScience, Inc.	Sep 23, 2016	BuyD (derivative)	5,714,286	—	—	SEC
INTERLEUKIN GENETICS INC	Aug 2, 2016	Buy	20,120,724	0.10 USD	$2M	SEC
INTERLEUKIN GENETICS INC	Aug 2, 2016	BuyD (derivative)	20,120,724	0.00 USD	—	SEC
ARDELYX, INC.	Jul 20, 2016	Buy	763,651	8.73 USD	$6.7M	SEC
ARDELYX, INC.	Jul 20, 2016	Buy	763,650	8.73 USD	$6.7M	SEC
TESARO, Inc.	Mar 18, 2016	Buy	710,429	35.19 USD	$25M	SEC
TESARO, Inc.	Mar 18, 2016	Buy	710,429	35.19 USD	$25M	SEC
ARDELYX, INC.	Jan 14, 2016	Buy	500,000	10.00 USD	$5M	SEC
ARDELYX, INC.	Jan 14, 2016	Buy	500,000	10.00 USD	$5M	SEC
Epizyme, Inc.	Jan 12, 2016	Buy	1,111,111	9.00 USD	$10M	SEC
Avalo Therapeutics, Inc.	Oct 20, 2015	Other	594,245	—	—	SEC
Avalo Therapeutics, Inc.	Oct 20, 2015	OtherD (derivative)	-16,638,880	0.00 USD	—	SEC
Mirna Therapeutics, Inc.	Oct 6, 2015	OtherD (derivative)	-1,241,650	—	—	SEC